Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

about

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.

P2860

Q33688577-24E78089-DCDC-4BBE-B130-D147C167C1FF Q54963896-37A6D8E3-7442-4CCA-B0EF-FEA9B6BC75ED

P2860

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

Item

http://www.wikidata.org/entity/Q36544718

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@ast

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@en

type

Item

label

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@ast

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@en

prefLabel

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@ast

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@en

P1476

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

@en

P2093

Bruno Nervi

http://www.w3.org/2001/XMLSchema#string

Hana Kunkel

http://www.w3.org/2001/XMLSchema#string

Helga Weber

http://www.w3.org/2001/XMLSchema#string

Juan C Araya

http://www.w3.org/2001/XMLSchema#string

Manuel Grez

http://www.w3.org/2001/XMLSchema#string

Pamela Leal

http://www.w3.org/2001/XMLSchema#string

Patricia García

http://www.w3.org/2001/XMLSchema#string

Stefan Stein

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR: from growth signal integration to cancer, diabetes and ageing

mTOR signaling in growth control and disease

Targeting the mTOR signaling network for cancer therapy

Rapalogs in cancer prevention: anti-aging or anticancer?

Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway

mTOR and cancer: many loops in one pathway.

Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.

P304

31877-31888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5047

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282129167

http://www.w3.org/2001/XMLSchema#string

P698

26397134

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

4741647

http://www.w3.org/2001/XMLSchema#string

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

about

P2860

P2860

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932